New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
07:13 EDTNNVCNanoViricides signs confidential disclosure agreement with Viroclinics
NanoViricides has signed a “confidential disclosure agreement" with Viroclinics Biosciences, BV, a spinoff of the Department of Viroscience at the Erasmus Medical Centre in Rotterdam, the Netherlands. The agreement will allow the scientists at Viroclinics to develop a specific proposal for the testing of different nanoviricides , such as FluCide, against viruses of mutual interest to both organizations.
News For NNVC From The Last 14 Days
Check below for free stories on NNVC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
17:11 EDTNNVCNanoViricides files to sell 3.07M shares of common stock for holders
July 14, 2014
08:16 EDTNNVCNanoViricides presents NV-INF-1 pre-clinical data
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use